These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 765496

  • 21. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
    O'Toole C, Perlmann P, Wigzell H, Unsgaard B, Zetterlund CG.
    Lancet; 1973 May 19; 1(7812):1085-8. PubMed ID: 4123535
    [No Abstract] [Full Text] [Related]

  • 22. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M, Mickey MR, Terasaki PI.
    J Natl Cancer Inst; 1974 Dec 19; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract] [Full Text] [Related]

  • 23. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D, Jäger E, Bert F, Knuth A.
    Cancer Chemother Biol Response Modif; 2001 Dec 19; 19():385-93. PubMed ID: 11686025
    [No Abstract] [Full Text] [Related]

  • 24. Immunologic approaches to the diagnosis of cancer.
    Herberman RB.
    Cancer; 1976 Jan 19; 37(1 suppl):549-61. PubMed ID: 55303
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE.
    N Engl J Med; 1974 Sep 26; 291(13):637-41. PubMed ID: 4859212
    [No Abstract] [Full Text] [Related]

  • 33. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M, Kinoshita K.
    J Natl Cancer Inst; 1974 Dec 26; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
    Mangsbo SM, Broos S, Fletcher E, Veitonmäki N, Furebring C, Dahlén E, Norlén P, Lindstedt M, Tötterman TH, Ellmark P.
    Clin Cancer Res; 2015 Mar 01; 21(5):1115-26. PubMed ID: 25316820
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.